EM Imaging obtains global licence for optical agent that detects cancer early
25-Sep-2015 -
Edinburgh Molecular Imaging Ltd. (EM Imaging) has signed an exclusive global license for a novel optical imaging agent that could improve the detection of early-stage colorectal cancer. EM Imaging signed the licensing agreement with GE Healthcare Ltd. EM Imaging will now complete the development ...
colonoscopy
colorectal cancer